Jim Cramer made the following calls on June 19th, 2013. What do you think about his picks?
Celldex Therapeutics (NASDAQ:CLDX): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 31, 2013. The stock’s 52-week high is $16.48, and its 52-week low is $4.30. “It’s a great spec play,” said Cramer. “I recommended it on the show a few weeks ago and I stand by that recommendation.”